← All diseases Cancer

Multiple myeloma

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (64)Meta-analysis (11)Treatment guideline (2)Systematic review (24)Randomized trial (16)Phase 3 study (11)Clinical trial (628)Review Article (260)Early study (phase 1 or 2) (44)Case Reports (256)Laboratory or animal study (23)Commentary or editorial (45)Retracted Publication (4)Concerns have been raised (1) Studies currently recruiting participants only (46)

Filter

Publications and studies (2183)

• Clinical Features and Outcomes of Patients with Double-Hit/Triple-Hit Multiple Myeloma Detected at Relapse. (2023/01/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. A systematic review on performance analysis of critical time points in multiple myeloma treated by CAR-T cell immunotherapy. (2023/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Imaging for Multiple Myeloma according to the Recent International Myeloma Working Group Guidelines: Analysis of Image Acquisition Techniques and Response Evaluation in Whole-Body MRI according to MY-RADS]. (2023/01/01) ♡
• Analysis of signaling cascades from myeloma cells treated with pristimerin. (2023/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma. (2023/01/01) ♡
• Estimation of Kidney Function in Patients With Multiple Myeloma: Implications for Lenalidomide Dosing. (2023/01/01) ♡
• Perturbation of the gut microbiome and association with outcomes following autologous stem cell transplantation in patients with multiple myeloma. (2023/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Impact of diet and antibiotics on gut microbiota and outcomes in patients with multiple myeloma treated with autologous hematopoietic stem cell transplantation. (2023/01/01) ♡
• Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma. (2023/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Artificially Sweetened Beverages Beyond the Metabolic Risks: A Systematic Review of the Literature. (2023/01/01) ♡
• Neurobiology of multiple myeloma and its therapeutical use - results of the pilot study with a control arm. (2023/01/01) ♡
• Dissecting molecular mechanisms of immune microenvironment dysfunction in multiple myeloma and precursor conditions. (2023/01/01) ♡
• An elevated systemic inflammation index is related to an inferior response to pomalidomide and dexamethasone treatment in patients with relapsed and refractory multiple myeloma. (2023/01/01) ♡
• Successful Treatment with Bortezomib for Refractory Thrombotic Thrombocytopenic Purpura Associated with Systemic Lupus Erythematosus. (2022/12/31) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance. (2022/12/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma. (2022/12/30) ♡
• Liposome-Encapsulated Melphalan Exhibits Potent Antimyeloma Activity and Reduced Toxicity. (2022/12/29) ♡
• MYC Causes Multiple Myeloma Progression via Attenuating TP53-Induced MicroRNA-34 Expression. (2022/12/29) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Solitary hyoid plasmacytoma with unicentric Castleman disease: A case report and review of literature. (2022/12/26) ♡
• A Novel Radiographic Pattern Related to Poor Prognosis in Patients with Prostate Cancer with Metastatic Spinal Cord Compression. (2022/12/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Drug Resistance: The Role of Exosomal miRNA in the Microenvironment of Hematopoietic Tumors. (2022/12/23) ♡
• AIM™ platform: A new immunotherapy approach for viral diseases. (2022/12/23) ♡
• Bleeding risk in patients with multiple myeloma treated for venous thromboembolism: a MarketScan analysis. (2022/12/23) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chimeric antigen receptor T-cell therapy for multiple myeloma. (2022/12/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A review of recent advances on single use of antibody-drug conjugates or combination with tumor immunology therapy for gynecologic cancer. (2022/12/22) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: Reviews in hematologic malignancies. (2022/12/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Animal models of chemotherapy-induced peripheral neuropathy for hematological malignancies: A review. (2022/12/22) ♡
• The utility of chest ultrasound-guided fine-needle biopsy in the diagnosis of plasmacytoma. (2022/12/19) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case of Plasmablastic Multiple Myeloma With Extramedullary Disease Manifesting as a Myelomatous Pleural Effusion. (2022/12/16) ♡
• Clinicopathological and laboratory parameters of plasma cell leukemia among Indian population. (2022/12/15) ♡
• The guidelines for diagnosis and treatment of myeloma bone disease in China (2022). (2022/12/14) ♡
• New agents-based induction chemotherapy followed by autologous stem cell transplantation and maintenance treatment strategy for multiple myeloma: a single center retrospective study of 300 cases. (2022/12/14) ♡
• A case-control study of multiple myeloma patients with central nervous system involvement. (2022/12/14) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multiple myeloma with chromothripsis: three cases report. (2022/12/14) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Monoclonal gammopathy of undetermined significance with recurrent skin bleeding: a case report. (2022/12/14) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Rheumatoid arthritis and risk of site-specific cancers: Mendelian randomization study in European and East Asian populations. (2022/12/13) ♡
• Ectopic CH60 mediates HAPLN1-induced cell survival signaling in multiple myeloma. (2022/12/13) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Polycytidine tract deletion from microRNA-detargeted oncolytic Mengovirus optimizes the therapeutic index in a murine multiple myeloma model. (2022/12/02) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Severe lung injury induced by CD38 monoclonal antibody Daratumumab and bortezomib-containing regimen in a patient with preexisting interstitial lung disease: a case report and literature review. (2022/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Prognostic role of controlling nutritional status score in hematological malignancies. (2022/12/01) ♡
• Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets. (2022/12/01) ♡
• Exploring health behaviors and the feasibility of a lifestyle intervention for patients with multiple myeloma. (2022/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Synchronous Presentation of Autoimmune Hepatitis and Multiple Myeloma. (2022/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Disseminated Histoplasmosis: An Unusual Cause of Bowel Obstruction. (2022/12/01) ♡
• Bioinformatics analysis of the prognostic biomarkers and predictive accuracy of differentially expressed genes in high-risk multiple myeloma based on Gene Expression Omnibus database mining. (2022/12/01) ♡
• The potential of glutamine metabolism-related long non-coding RNAs (lncRNAs) as prognostic biomarkers in multiple myeloma patients. (2022/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies. (2022/12/01) ♡
• Head and Neck Manifestations of Multiple Myeloma. (2022/12/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Chemotherapy-driven gut dysbiosis in patients with multiple myeloma. (2022/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. A plain language summary of daratumumab plus lenalidomide/bortezomib/dexamethasone in transplant-eligible Black patients with newly diagnosed multiple myeloma in the GRIFFIN study. (2022/12/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.